Atorvastatin

C-C motif chemokine ligand 2 ; Homo sapiens







32 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33959001 A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro. 2021 2
2 31293514 The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome. 2019 1
3 28577105 Effect of Atorvastatin Therapy on the Level of CD34+CD133+CD309+ Endothelial Progenitor Cells in Patients with Coronary Heart Disease. 2017 May 1
4 25595138 Atorvastatin in combination with inhaled beclometasone modulates inflammatory sputum mediators in smokers with asthma. 2015 Apr 1
5 26084792 Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia. 2015 1
6 25234816 Atorvastatin reduces the proadhesive and prothrombotic endothelial cell phenotype induced by cocaine and plasma from cocaine consumers in vitro. 2014 Nov 1
7 25464609 [Effect of atorvastatin on pro-inflammatory status (in vivo and in vitro) in patients with essential hypertension and metabolic syndrome]. 2014 1
8 23792106 Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses. 2013 Oct 2
9 22109668 The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. 2012 Mar 1
10 22815786 Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies. 2012 1
11 21216561 The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray. 2011 Mar 1
12 21651980 Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products. 2011 Sep 2
13 21924076 [Effect of atorvastatin on advanced glycation end products induced monocyte chemoattractant protein-1 expression in cultured human endothelial cells]. 2011 Jun 5
14 20074254 Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. 2010 Spring 4
15 20410153 Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus. 2010 Jul 1
16 21273686 Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia. 2010 Nov-Dec 1
17 18973470 Statins for heart failure: still caught in no man's land? 2009 Jan 2
18 19151033 Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. 2009 Mar 1
19 18089573 Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells. 2008 Feb 22 2
20 17442054 Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. 2007 Aug 3
21 17452168 Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. 2007 May 1
22 18167242 [Influence of atorvastatin on the expression of monocyte chemoattractant protein-1 in peritoneal mesothelial cells by high glucose]. 2007 Oct 16 6
23 16002160 The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level. 2006 Apr 28 1
24 16503719 Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors. 2006 Mar 1
25 15772519 Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia. 2005 Apr 4
26 16125534 The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia. 2005 Sep 1
27 15290911 Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin. 2004 May 1
28 12756509 Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. 2003 Jul 4
29 12816876 Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins. 2003 Sep 1 1
30 14637261 Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome. 2003 Dec 6
31 11926313 Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes. 2002 Feb 1
32 10559511 Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. 1999 Dec 1